SND1 and non-small cell lung carcinoma: Consistent with our previous study [20], in the current study, silencing SND1 rendered NSCLC cells more susceptible to the induction of apoptosis and induced sensitization of NSCLC cells to chemotherapeutic agents (Fig. 1E, F; Fig. S3A, B), demonstrating that SND1 functions as an essential mediator of NSCLC chemoresistance.